-
Rutgers Cancer Institute names director of investigational therapeutics program
Rutgers Cancer Institute of New Jersey named Sanjay Goel, MD, director of its investigational therapeutics program, it said Feb. 16. -
MD Anderson receives $31.7M from research institute
The University of Texas MD Anderson Cancer Center was awarded $31.7 million from the Cancer Prevention and Research Institute of Texas, the center said Feb. 16. -
MD Anderson renews Banner Health partnership
The University of Texas MD Anderson Cancer Center extended its partnership with Phoenix-based Banner Health for another 10 years, the cancer center said Feb. 15. -
COVID-19 driving up late-stage cancer diagnoses, small study suggests
Delayed screenings as a result of the COVID-19 pandemic have led to later-stage cancer diagnoses, a small study published Feb. 15 in JAMA Network Open suggests. -
4 recent leadership changes at Yale Cancer Center
Yale Cancer Center recently made several leadership changes. -
Mayo Clinic model predicts therapy benefits for gastric cancer patients
The use of genomic sequencing to predict the likelihood that gastric cancer patients will benefit from chemotherapy or from immunotherapy has been validated by findings in a study published Feb. 9 in Nature Communications. -
Viewpoint: We don't have to wait for the 'cancer moonshot' to save more lives
While the White House's revival of the Cancer Moonshot — a program to cut cancer deaths by 50 percent over the next 25 years — is an ambitious and important goal, more can be done today to benefit cancer patients, according to Edward Abrahams, PhD. -
5 recent cancer study findings
Recent cancer research has findings on cancer trends among African Americans and the impact of COVID-19 on cancer research. -
Yale Cancer Center names first deputy director of clinical affairs
Yale Cancer Center appointed Roy Herbst, MD, its inaugural deputy director of clinical affairs at the center and New Haven, Conn.-based Smilow Cancer Hospital, the center said last week. -
Breast cancer now leading cause of cancer deaths for African American women
Breast cancer has replaced lung cancer as the leading cause of cancer death among African American women, according to a report published Feb. 10 in CA: A Cancer Journal for Clinicians. -
Yale Cancer Center makes 3 leadership appointments
Yale Cancer Center named three new leaders Feb. 10. -
Banner MD Anderson opens cancer therapeutics research institute
Gilbert, Ariz.-based Banner MD Anderson Cancer Center launched a cancer therapeutics research institute, AZBigMedia reported Feb. 10. -
4 oncologists on the move
These four oncologists joined new practices or received new appointments over the last few weeks. -
COVID-19's impact on cancer research, care: 6 report findings
Nearly 10 million cancer screenings were delayed in the U.S. from January to July 2020 as a result of the COVID-19 pandemic, an American Association of Cancer Research report published Feb. 9 found. -
4 recent American Cancer Society moves
Here are four announcements from the American Cancer Society reported by Becker's since Jan. 14: -
5 recent cancer partnerships
Here are five oncology-related partnerships Becker's has covered since Jan. 25: -
Improved diagnostics needed for breast cancer treatment, Yale study finds
Current tests for HER2 breast cancer may cause misassignment in treatment types, driving a need to create a new test, a Yale Cancer Center study published Feb. 3 in JAMA Oncology found. -
5 recent gifts to cancer centers, research
Hundreds of millions of dollars have been donated to fund specialty cancer centers and accelerate cancer research in recent weeks. -
American Cancer Society to research effects of sleep quality on cancer patients
The American Cancer Society and Sleep Number Corp. have agreed to work together on sleep research to inform the first sleep guidelines for cancer patients, the organizations said Feb. 2. -
CAR T therapy recipients cancer-free after a decade, researchers find
Two early recipients of CAR T-cell therapy — who had chronic lymphocytic leukemia at the time of treatment — remain cancer-free a decade later, researchers from the University of Pennsylvania in Philadelphia reported Feb. 2.
Page 46 of 50